Group Molenaar

Medicijnen en Levenswetenschappen

1. Neuroblastoma 100%
2. Neoplasms 37%
3. Pediatrics 36%
4. Organoids 25%
5. Preclinical Drug Evaluations 14%
6. Investigational Therapies 13%
7. Immunotherapy 11%
8. Therapeutics 11%
9. Rhabdoid Tumor 11%
10. T-Lymphocytes 10%
11. RG7388 9%
12. Pharmaceutical Preparations 9%
13. ch14.18 monoclonal antibody 9%
14. Child 9%
15. Mutation 9%
16. Cell Line 7%
17. Drug Development 6%
18. Clustered Regularly Interspaced Short Palindromic Repeats 6%
19. Precision Medicine 6%
20. YM 155 6%
21. Precursor Cell Lymphoblastic Leukemia-Lymphoma 6%
22. Liquid Biopsy 6%
23. pyrvinium 6%
24. venetoclax 5%
25. ribonucleotide reductase M2 5%
26. Checkpoint Kinase 1 5%
27. Rhabdomyosarcoma 5%
28. Whole Genome Sequencing 5%
29. In Vitro Techniques 5%
30. Diffuse Intrinsic Pontine Glioma 5%
31. Anaplastic Lymphoma Kinase 5%
32. Neutrophils 5%
33. DNA Repair 5%
34. Immunologic Monitoring 5%
35. RNA Sequence Analysis 5%
36. Ganglioneuroblastoma 5%
37. Mitogen-Activated Protein Kinase Kinases 5%
38. Cell Lineage 5%